[Clinical experience with a test of pituitary reserve].
A test of pituitary reserve was used in the investigation of 14 children with retarded growth and 15 adults with endocrine disorders. Mepyrapone (Metopiron), 500 mg. every four hours, was administered orally for 48 hours. The pituitary response was determined by the amount of 17-hydroxycorticosteroid in a 24-hour urine sample (by a modification by Peterson of the Porter-Silber method). Pituitary reserve was decreased in four patients who were pituitary dwarfs, one who had retarded growth, two patients with Sheehan's syndrome, three with pituitary tumours, one who had panhypopituitarism without a tumour, and one case of limited adrenal reserve (confirmed by a negative response to ACTH stimulation). The pituitary reserve was normal in three patients with gonadal dysgenesis, three who exhibited retarded growth, one case of diabetes insipidus, one cretin, one patient treated by steroids, three with psychogenic amenorrhea, and five normal controls. It is concluded that this test of pituitary reserve is useful in the assessment of children with growth retardation and in establishing the diagnosis of pituitary insufficiency in adults.
D015065:17-Hydroxycorticosteroids; D000328:Adult; D002648:Child; D003919:Diabetes Insipidus; D005260:Female; D006801:Humans; D007018:Hypopituitarism; D008297:Male; D008797:Metyrapone; D010900:Pituitary Diseases; D010902:Pituitary Gland; D010911:Pituitary Neoplasms
D015065:17-Hydroxycorticosteroids; D008797:Metyrapone
HYPOPITUITARISM